More insight into effects of treatment with PCSK9 inhibition from 5 new FOURIER analyses
AHA 2017 - Anaheim, CA, USA
AHA 2017 Dr. Giugliano summarises findings of 2 additional clinical trial updates and studies into infarct size, TIMI stable IHD risk and total events in the FOURIER trial.
Educational information
This 3-minute education provides a summary of just presented scientific data, recorded during the AHA 2017 congress. The objective is to provide a brief commentary and potential implications of these findings.
Disclosures
- Our reporting is based on the information provided at the AHA 2017 congress -
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: